Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based platform, delivers actionable insights into therapies to our pharmaceutical and biotech partners. Oncimmune’s ImmunoINSIGHTS platform enables life-science organisations to optimise drug development and delivery, leading to more effective targeted as well as safer treatments for patients. Oncimmune is headquartered in the UK, with a discovery research centre in Dortmund, Germany and an office in Cambridge MA, USA.
View Top Employees from Oncimmune| Website | http://www.oncimmune.com |
| Revenue | $19.9 million |
| Employees | 51 (47 on RocketReach) |
| Founded | 2006 |
| Phone | +44 115 784 0500 |
| Technologies |
JavaScript,
HTML,
Twitter
+16 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Other Healthcare Technology Systems, Lung cancer, Business Services, Laboratory Services (Healthcare), Early cancer detection, Autoantibodies, Pulmonary nodules, Lung cancer detection |
| Web Rank | 5 Million |
| Keywords | Probability Of Lung Cancer, Lung Cancer Risk Calculator, 5 Pack Years Lung Cancer, Early Cdt®- Lung, Lung Camcer Risk Assessment Tool Smoking |
| Competitors | Amadix, Artios, Bicycle Therapeutics, Biosignatures Ltd, Lucence |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Oncimmune employee's phone or email?
Oncimmune Questions
The Oncimmune annual revenue was $19.9 million in 2024.
Mike Fisher is the Vice President, Head of Business Development of Oncimmune.
47 people are employed at Oncimmune.
The NAICS codes for Oncimmune are [32541, 3254, 325, 32].
The SIC codes for Oncimmune are [28, 283].
Top Oncimmune Employees
-
3
-
2
-
32
-
22
-
31
-
5+1
-
3
-
Related Companies
